the company
Adverse drug reactions represent a major health problem
The Spin-Off Company ADR-AC GmbH was founded by Prof. Dr. med. W.J. Pichler in 2006. The basis of ADR-AC is the unique combination of clinical and experimental experience in the field of drug hypersensitivity.
The company is based on three major branches:
ADR–AC GmbH has the aim to
- promote drug allergy research
- offer tests to identify sensitizing drugs
- monitor possible sensitizations to drugs during phase 1-3 studies
- develop tests to predict the sensitizing potential of a drug